Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is now a common cause of cancer death, with no obvious change in patient survival over the past few years. Although the traditional therapeutic modalities for HCC patients mainly involved in surgery, chemotherapy, and radiotherapy, which have achieved admirable achieve...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Shijing, Zhao, Ruirui, Zhang, Bingchen, Lai, Chunmei, Li, Linyan, Shen, Jiangwen, Tan, Xiarong, Shao, Jingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424087/
https://www.ncbi.nlm.nih.gov/pubmed/37583709
http://dx.doi.org/10.1016/j.ajps.2023.100828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424087/
https://www.ncbi.nlm.nih.gov/pubmed/37583709
http://dx.doi.org/10.1016/j.ajps.2023.100828

Ejemplares similares